Nociti, Viviana
 Distribuzione geografica
Continente #
EU - Europa 3.555
NA - Nord America 3.438
AS - Asia 843
AF - Africa 19
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 7.886
Nazione #
US - Stati Uniti d'America 3.426
DE - Germania 1.476
SE - Svezia 728
CN - Cina 474
UA - Ucraina 344
IT - Italia 240
FR - Francia 216
IE - Irlanda 167
SG - Singapore 149
GB - Regno Unito 122
IN - India 111
FI - Finlandia 78
RU - Federazione Russa 78
TR - Turchia 46
PL - Polonia 31
BE - Belgio 28
JP - Giappone 21
IR - Iran 17
CI - Costa d'Avorio 15
CA - Canada 12
VN - Vietnam 10
AU - Australia 9
NL - Olanda 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CH - Svizzera 6
CL - Cile 6
CZ - Repubblica Ceca 5
RO - Romania 5
AT - Austria 4
BR - Brasile 4
HK - Hong Kong 4
IL - Israele 4
MD - Moldavia 4
BG - Bulgaria 3
ES - Italia 3
EU - Europa 3
CO - Colombia 2
HU - Ungheria 2
PH - Filippine 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
UZ - Uzbekistan 1
Totale 7.886
Città #
Chandler 758
Ashburn 301
Jacksonville 246
Ann Arbor 191
San Mateo 178
Dublin 167
Nürnberg 116
Nanjing 115
Wilmington 105
Dearborn 101
New York 101
Singapore 89
Woodbridge 77
Princeton 62
Houston 61
Boston 60
Moscow 52
Marseille 50
Bremen 45
Izmir 44
Milan 44
Redwood City 43
Norwalk 42
Nanchang 41
Seattle 41
Beijing 40
Lawrence 35
Cattolica 32
Los Angeles 32
Chicago 29
Fairfield 29
Brussels 27
Detroit 27
Munich 26
Kraków 24
Mountain View 24
Kunming 23
Hebei 22
Rome 22
University Park 22
Shenyang 21
Boardman 20
Jiaxing 19
Shanghai 16
Tianjin 16
Abidjan 15
Fremont 15
Guangzhou 14
Hefei 14
Leawood 13
Redmond 12
Zhengzhou 12
Falls Church 11
Ottawa 11
Pune 11
Changsha 9
Hanoi 9
Helsinki 9
Fairport 8
Hangzhou 8
Simi Valley 8
Verona 8
Indiana 7
Jinan 7
Changchun 6
Edinburgh 6
Florence 6
Kansas City 6
Buffalo 5
Fuzhou 5
Lancaster 5
Lviv 5
Melbourne 5
Naples 5
Warsaw 5
Washington 5
Auburn Hills 4
Chisinau 4
Coquimbo 4
Hong Kong 4
Modena 4
Zurich 4
Andover 3
Atlanta 3
Augusta 3
Cambridge 3
Cerro Maggiore 3
Chengdu 3
Dallas 3
Easton 3
Lanzhou 3
Nibionno 3
Olcenengo 3
Orange 3
Philadelphia 3
Saint Louis 3
Septeme 3
Sofia 3
Amsterdam 2
Ardabil 2
Totale 3.977
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 208
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 193
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 177
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 156
Multiple Sclerosis attacks triggered by hyperprolactinemia 152
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 151
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 151
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 146
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 133
Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? 131
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 131
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 125
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 123
A Case of Hemiabdominal Myoclonus 120
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 117
Migraine-like headache and status migrainosus as attacks of Multiple Sclerosis in a child. 116
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 116
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 111
Pneumonia's link with the head and heart. 106
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 106
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 106
Movement disorders in multiple sclerosis: Causal or coincidental association? 101
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 100
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 98
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 98
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 96
Type 1 immune response in progressive Multiple Sclerosis 93
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 93
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 92
Pneumonia's link with the head and the heart 89
Coeliac disease presenting with acute disseminated encephalomyelitis 88
Tourettism in multiple sclerosis: a case report 87
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 87
Serum lactate as a novel potential biomarker in multiple sclerosis 85
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 85
Breastfeeding and multiple sclerosis 84
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients 83
Case of postpartum Parsonage-Turner syndrome 80
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 79
Chronic migraine-like headache caused by a demyelinating lesion in the brainstem 78
Teaching NeuroImages: Autosomal dominant leukodystrophy in a sporadic case. 78
Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection 77
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 77
Multiple sclerosis attacks triggered by hyperprolactinemia 76
A Case of Hemiabdominal Myoclonus 75
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 74
Glioblastoma in multiple sclerosis: a case report 73
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 73
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 73
Coeliac disease presenting with acute disseminated encephalomyelitis. 72
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 72
Focal hyperhidrosis in tumefactive Multiple Sclerosis 71
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 71
Fingolimod vs dimethyl fumarate in multiple sclerosis 71
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 70
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 70
Clinical characteristics, course and prognosis of spinal multiple sclerosis 68
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 68
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 66
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 65
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 63
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 62
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 61
Posterior reversible encephalopathy syndrome after intramuscular oxygen-ozone therapy 60
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 59
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 58
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 58
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 57
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 57
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 56
What do we know about the role of lncRNAs in multiple sclerosis? 56
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 55
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 55
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 54
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 54
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta 53
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 53
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 51
A unique case of multiphasic ADEM or what else? 51
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 50
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 49
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 47
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 47
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 47
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 47
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 46
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients 44
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 44
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 44
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 42
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 42
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 39
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 38
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 35
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study 30
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 30
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 25
Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects 25
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 23
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 21
Totale 7.899
Categoria #
all - tutte 30.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.012 0 0 80 33 135 181 86 31 113 80 190 83
2020/2021824 36 69 24 72 84 44 80 34 90 61 200 30
2021/2022959 98 78 18 120 29 38 17 141 48 55 130 187
2022/20232.007 224 283 164 319 121 276 101 183 233 31 53 19
2023/2024907 35 269 26 59 24 122 92 27 21 24 103 105
2024/2025121 54 67 0 0 0 0 0 0 0 0 0 0
Totale 8.009